您好,欢迎来到佐思信息
全国服务热线:
400-009-0050
佐思信息专注支持企业决策
您当前的位置:首页>>研究报告>>其他医疗设备

2016-2021年试管受精市场研究报告
In Vitro Fertilization Market by Product (Incubators, Cryosystem, Sperm Seperation System, Cryopreservation Media, Embryo Culture Media), Technology (Pre-Implantation Genetic Diagnosis, Intra-Cytoplasmic Sperm Injection) & End Users - Forecast to 2021

2016-2021年试管受精市场研究报告
【报告编号】:No.25868
【发布时间】:2016-07
【关 键 字】:In Vitro Fertilization    试管受精        
【报告页数】:161页
【报告价格】:电子版:5650美元
【交付方式】:Email发送或EMS快递
【订购热线】:


400-009-0050(全国24小时服务)
北京:010-82863481
上海:021-64871266 021-64872612

报告目录下载订购协议下载在线咨询

    专业、专注于为企业提供真正有价值的全球市场调查信息,是我们的使命。我们是中国第一家汇集全球众多行业研究机构研究成果的平台,致力于为企业决策提供最有效的市场资讯,特别是为中国企业了解和进入国际市场迈出第一步,提供全面的信息参考,我们跨越语言及时间的障碍,在信息爆炸的当下,努力为客户提供最有价值的全球产业资讯。我们公司也拥有独立的研究机构,聚焦于中国市场的研究,为国内外企业在中国市场大展宏图提供市场研究支持。

• 我们在全球的合作伙伴>>• 我们的研究中心>>

  • 英文摘要
  • 中文摘要
  • 索取简版报告
  • 其他医疗设备行业的相关报告
Report Description
 
The in vitro fertilization market is expected to reach USD 756.7 million by 2021 from USD 468.3 million in 2016, at a CAGR of 10.1%. Factors such as declining fertility rates, growth in the media age of first-time motherhood, growing cases of male infertility, growth in healthcare expenditure, rise in consumption of alcohol and cigarettes, implementation of government initiatives and introduction of new and advanced products are driving the in vitro fertilization market. However, high cost coupled with low success rate, and restrictive regulation and ethical concerns are expected to restrain the growth of this market to a certain extent.
 
The intra-cytoplasmic sperm injection segment accounted for the largest share of the global in vitro fertilization market, by technology, in 2016. Growing incidence of male infertility is contributing to the large share of this segment. The embryo culture media accounted for the largest share of the global in vitro fertilization market, by reagents, in 2016 and is expected to grow at the highest CAGR during the forecast period. Imaging systems segment accounted for the largest share of the global in vitro fertilization market, by equipment, in 2016. However, sperm separation systems are expected to grow at the highest CAGR during the forecast period. The fertility and surgical centers segment accounted for the largest share of the global in vitro fertilization market, by end user, in 2016. 
 
Asia-Pacific accounted for the largest share of the in vitro fertilization market in 2016, followed by Europe and North America. The large share of the Asia-Pacific in vitro fertilization market can primarily be attributed to the high maternal age in Japan, abolishment of China’s one child policy, rising fertility tourism in India and Thailand, growing surrogacy and high prevalence of PCOS in India and growing number of ART procedures in Australia and New Zealand. In addition, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period.
 
Major players in the market are focusing on various strategies such as agreements, alliances, collaborations, and partnerships; new product launches; acquisitions; product approvals; expansions; and other strategies (product enhancement and spin-off), to establish a strong foothold in the global in vitro fertilization market..
 
CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ESCO Micro Pte. Limited (Singapore), Genea Limited (Australia), The Baker Company (U.S.), IVFtech ApS (Denmark) and EMD Serono, Inc. (U.S.) are some of the key players in the global in vitro fertilization market.    
 
Reasons to Buy the Report: 
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
 
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the solutions offered by the top players in the in vitro fertilization market. The report analyzes the in vitro fertilization market, by technology, product, end user, and region. 
• Product Development/Innovation: Detailed insights on research and development activities and new product launches in the in vitro fertilization market  
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for in vitro fertilization across regions
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the in vitro fertilization market 
• Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the in vitro fertilization market  
 
Table of Contents
 
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
 
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH METHODOLOGY STEPS 18
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19
2.2.1 SECONDARY RESEARCH 19
2.2.1.1 Key data from secondary sources 19
2.2.2 PRIMARY RESEARCH 20
2.2.2.1 Key data from primary sources 21
2.2.2.2 Key Insights from primary sources 22
2.3 MARKET SIZE ESTIMATION METHODOLOGY 22
2.3.1 RESEARCH DESIGN 24
2.4 MARKET DATA VALIDATION AND TRIANGULATION 25
2.5 ASSUMPTIONS FOR THE STUDY 26
 
3 EXECUTIVE SUMMARY 27
3.1 CURRENT SCENARIO 27
3.2 FUTURE OUTLOOK 29
3.3 CONCLUSION 31
 
4 PREMIUM INSIGHTS 32
4.1 GLOBAL IN VITRO FERTILIZATION: MARKET OVERVIEW 32
4.2 GEOGRAPHICAL ANALYSIS: IN VITRO FERTILIZATION MARKET, BY TECHNOLOGY 33
4.3 IN VITRO FERTILIZATION MARKET SHARE, BY END USER (2016 VS. 2021) 34
 
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.3 MARKET DYNAMICS 37
5.3.1 DRIVERS 37
5.3.1.1 Growth in median age of first-time motherhood 37
5.3.1.2 Declining fertility rates 38
5.3.1.3 Growing cases of male infertility 39
5.3.1.4 Growing consumption of alcohol and cigarettes 39
5.3.1.5 Implementation of government initiatives to promote IVF treatments 40
5.3.1.6 Introduction of new and advanced products 40
5.3.2 RESTRAINTS 41
5.3.2.1 High cost and low success rate of IVF treatments 41
5.3.2.2 Restrictive regulations and ethical concerns 41
5.3.3 OPPORTUNITIES 42
5.3.3.1 Fertility tourism 42
5.3.4 CHALLENGE 42
5.3.4.1 Reduction in efficacy of infertility treatments with advancing age 42
 
6 IN VITRO FERTILIZATION MARKET, BY PRODUCT 43
6.1 INTRODUCTION 44
6.2 REAGENTS 45
6.2.1 EMBRYO CULTURE MEDIA 46
6.2.2 CRYOPRESERVATION MEDIA 46
6.2.3 SPERM PROCESSING MEDIA 47
6.2.4 OVUM PROCESSING MEDIA 48
6.3 EQUIPMENT 49
6.3.1 IMAGING SYSTEMS 51
6.3.2 SPERM SEPARATION SYSTEMS 52
6.3.3 CABINETS (WORKSTATIONS) 53
6.3.4 OVUM ASPIRATION PUMPS 54
6.3.5 INCUBATORS 54
6.3.6 MICROMANIPULATOR SYSTEMS 55
6.3.7 GAS ANALYZERS 56
6.3.8 LASER SYSTEMS 57
6.3.9 CRYOSYSTEMS 58
6.3.10 ANTI-VIBRATION TABLES 59
6.3.11 ACCESSORIES 60
 
7 IN VITRO FERTILIZATION MARKET, BY TECHNOLOGY 62
7.1 INTRODUCTION 63
7.2 INTRA-CYTOPLASMIC SPERM INJECTION (ICSI) 64
7.3 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) 65
7.4 FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) 65
7.5 OTHERS 66
 
8 IN VITRO FERTILIZATION MARKET, BY END USER 68
8.1 INTRODUCTION 69
8.2 FERTILITY AND SURGICAL CENTERS 70
8.3 HOSPITALS AND RESEARCH LABORATORIES 71
8.4 CRYOBANKS 72
 
9 IN VITRO FERTILIZATION MARKET, BY REGION 74
9.1 INTRODUCTION 75
9.2 NORTH AMERICA 76
9.2.1 U.S. 81
9.2.1.1 Rising postponement of childbirth 81
9.2.1.2 Declining fertility rates 81
9.2.1.3 Growing NGO support for IVF 81
9.2.2 CANADA 84
9.2.2.1 Rising maternal age 84
9.3 EUROPE 87
9.3.1 EUROPE-5 92
9.3.1.1 Declining birthrate in Germany 92
9.3.1.2 Government initiatives in Italy 92
9.3.1.3 Increasing obesity and PCOS rates in the U.K. 92
9.3.1.4 Rise of IVF tourism in Spain 93
9.3.1.5 Rising age of first-time pregnancy and rising obesity rate in France 93
9.3.2 REST OF EUROPE (ROE) 96
9.3.2.1 RoE: Regulatory laws regarding IVF 96
9.4 ASIA-PACIFIC (APAC) 100
9.4.1 JAPAN 104
9.4.1.1 High maternal age in Japan 104
9.4.1.2 Introduction of age cap of 42 for subsidized fertility treatment restricts market growth 104
9.4.2 CHINA 107
9.4.2.1 Abolishment of China’s one-child policy 107
9.4.3 INDIA 109
9.4.3.1 High prevalence of PCOS in India 109
9.4.3.2 Growing surrogacy in India 109
9.4.3.3 Rising fertility tourism in India 109
9.4.4 REST OF ASIA-PACIFIC 112
9.4.4.1 Fertility tourism driving the IVF market in Thailand 112
9.4.4.2 Growing number of ART procedures in Australia and New Zealand 112
9.5 REST OF THE WORLD (ROW) 115
9.5.1 INCREASING INCIDENCE OF RISK FACTORS CAUSING INFERTILITY 115
10 COMPETITIVE LANDSCAPE 119
10.1 OVERVIEW 119
10.2 MARKET SHARE ANALYSIS 119
10.2.1 INTRODUCTION 119
10.2.2 COOPERSURGICAL, INC. (A SUBSIDIARY OF COOPER COMPANIES, INC.) 119
10.2.3 VITROLIFE AB 120
10.3 COMPETITIVE SITUATION AND TRENDS 121
10.4 NEW PRODUCT LAUNCHES 122
10.5 ACQUISITIONS 123
10.6 AGREEMENTS, COLLABORATIONS, ALLIANCES, AND PARTNERSHIPS 124
10.7 PRODUCT APPROVALS 126
10.8 EXPANSIONS 127
10.9 OTHER STRATEGIES 128
 
11 COMPANY PROFILES 129
(Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 INTRODUCTION 129
11.2 COOPERSURGICAL, INC. (A SUBSIDIARY OF THE COOPER COMPANIES, INC.) 130
11.3 VITROLIFE AB 135
11.4 COOK MEDICAL, INC. 139
11.5 IRVINE SCIENTIFIC 141
11.6 THERMO FISHER SCIENTIFIC, INC. 144
11.7 EMD SERONO, INC. (SUBSIDIARY OF MERCK KGAA) 147
11.8 GENEA LIMITED 148
11.9 ESCO MICRO PTE. LIMITED 149
11.10 IVFTECH APS 150
11.11 THE BAKER COMPANY, INC. 151
*Details might not be captured in case of unlisted companies.
 
12 APPENDIX 152
12.1 DISCUSSION GUIDE 152
12.2 COMPANY DEVELOPMENTS (2013–2016) 155
12.2.1 VITROLIFE AB 155
12.2.2 IRVINE SCIENTIFIC 155
12.2.3 THERMO FISHER SCIENTIFIC, INC. 155
12.2.4 GENEA LIMITED 155
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 156
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 158
12.5 AVAILABLE CUSTOMIZATIONS 158
12.6 RELATED REPORTS 159
 
List Of Tables
TABLE 1 IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 44
TABLE 2 IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE, 
2014–2021 (USD MILLION) 45
TABLE 3 EMBRYO CULTURE MEDIA MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 46
TABLE 4 CRYOPRESERVATION MEDIA MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 47
TABLE 5 SPERM PROCESSING MEDIA MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 48
TABLE 6 OVUM PROCESSING MEDIA MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 49
TABLE 7 IN VITRO FERTILIZATION INSTRUMENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 50
TABLE 8 IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 51
TABLE 9 SPERM SEPARATION SYSTEMS MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 52
TABLE 10 CABINETS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 53
TABLE 11 OVUM ASPIRATION PUMPS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 54
TABLE 12 INCUBATORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 55
TABLE 13 MICROMANIPULATOR SYSTEMS MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 56
TABLE 14 GAS ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57
TABLE 15 LASER SYSTEM MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 58
TABLE 16 CRYOSYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 59
TABLE 17 ANTI-VIBRATION TABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 60
TABLE 18 ACCESSORIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 61
TABLE 19 IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY, 
2014–2021 (USD MILLION) 63
TABLE 20 INTRA-CYTOPLASMIC SPERM INJECTION MARKET SIZE, BY REGION,  
2014–2021 (USD MILLION) 64
TABLE 21 PRE-IMPLANTATION GENETIC DIAGNOSIS MARKET SIZE, BY REGION,  
2014–2021 (USD MILLION) 65
TABLE 22 FROZEN EMBRYO TRANSFER MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 66
TABLE 23 OTHER IN VITRO FERTILIZATION TECHNOLOGIES MARKET SIZE, BY REGION,  2014–2021 (USD MILLION) 67
TABLE 24 GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY END USER,  
2014–2021 (USD MILLION) 70
TABLE 25 FERTILITY AND SURGICAL CENTERS MARKET SIZE, BY REGION,  
2014–2021 (USD MILLION) 71
TABLE 26 HOSPITALS AND RESEARCH LABORATORIES MARKET SIZE, BY REGION,  
2014–2021 (USD MILLION) 72
TABLE 27 CRYOBANKS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 73
TABLE 28 IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 75
TABLE 29 NORTH AMERICA: IN VITRO FERTILIZATION MARKET SIZE, BY COUNTRY,  
2014–2021 (USD MILLION) 78
TABLE 30 NORTH AMERICA: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  2014–2021 (USD MILLION) 78
TABLE 31 NORTH AMERICA: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT,  
2014–2021 (USD MILLION) 79
TABLE 32 NORTH AMERICA: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  2014–2021 (USD MILLION) 79
TABLE 33 NORTH AMERICA: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  2014–2021 (USD MILLION) 80
TABLE 34 NORTH AMERICA: IN VITRO FERTILIZATION MARKET SIZE, BY END USER,  
2014–2021 (USD MILLION) 80
TABLE 35 NOTABLE ORGANIZATIONS PROVIDING SUPPORT FOR IVF TREATMENT, U.S. 82
TABLE 36 U.S.: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 82
TABLE 37 U.S.: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 82
TABLE 38 U.S.: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 83
TABLE 39 U.S.: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 83
TABLE 40 U.S.: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 84
TABLE 41 CANADA: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 85
TABLE 42 CANADA: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT,  
2014–2021 (USD MILLION) 85
TABLE 43 CANADA: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 86
TABLE 44 CANADA: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 86
TABLE 45 CANADA: IN VITRO FERTILIZATION MARKET SIZE, BY END USER,  
2014–2021 (USD MILLION) 87
TABLE 46 EUROPE: IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 89
TABLE 47 EUROPE: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 89
TABLE 48 EUROPE: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT,  
2014–2021 (USD MILLION) 90
TABLE 49 EUROPE: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 90
TABLE 50 EUROPE: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 91
TABLE 51 EUROPE: IN VITRO FERTILIZATION MARKET SIZE, BY END USER,  
2014–2021 (USD MILLION) 91
TABLE 52 AVERAGE COST OF IVF TREATMENT IN SPAIN (2016) 93
TABLE 53 EUROPE-5: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 94
TABLE 54 EUROPE-5: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT,  
2014–2021 (USD MILLION) 94
TABLE 55 EUROPE-5: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 95
TABLE 56 EUROPE-5: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 95
TABLE 57 EUROPE-5: IN VITRO FERTILIZATION MARKET SIZE, BY END USER,  
2014–2021 (USD MILLION) 96
TABLE 58 ROE: REGULATIONS FOR IVF 97
TABLE 59 ROE: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 97
TABLE 60 ROE: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 98
TABLE 61 ROE: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 98
TABLE 62 ROE: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 99
TABLE 63 ROE: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 99
TABLE 64 ASIA-PACIFIC: IN VITRO FERTILIZATION MARKET SIZE, BY REGION,  
2014–2021 (USD MILLION) 101
TABLE 65 ASIA-PACIFIC: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 101
TABLE 66 ASIA-PACIFIC: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT,  
2014–2021 (USD MILLION) 102
TABLE 67 ASIA-PACIFIC: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 102
TABLE 68 ASIA-PACIFIC: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 103
TABLE 69 ASIA-PACIFIC: IN VITRO FERTILIZATION MARKET SIZE, BY END USER,  
2014–2021 (USD MILLION) 103
TABLE 70 JAPAN: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 104
TABLE 71 JAPAN: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 105
TABLE 72 JAPAN: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 105
TABLE 73 JAPAN: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 106
TABLE 74 JAPAN: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 106
TABLE 75 CHINA: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 107
TABLE 76 CHINA: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 107
TABLE 77 CHINA: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 108
TABLE 78 CHINA: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 108
TABLE 79 CHINA: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 109
TABLE 80 INDIA: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 110
TABLE 81 INDIA: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 110
TABLE 82 INDIA: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 111
TABLE 83 INDIA: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 111
TABLE 84 INDIA: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 112
TABLE 85 ROAPAC: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 113
TABLE 86 ROAPAC: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT,  
2014–2021 (USD MILLION) 113
TABLE 87 ROAPAC: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 114
TABLE 88 ROAPAC: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 114
TABLE 89 ROAPAC: IN VITRO FERTILIZATION MARKET SIZE, BY END USER,  
2014–2021 (USD MILLION) 115
TABLE 90 ROW: IN VITRO FERTILIZATION MARKET SIZE, BY TECHNOLOGY,  
2014–2021 (USD MILLION) 116
TABLE 91 ROW: IN VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 117
TABLE 92 ROW: IN VITRO FERTILIZATION REAGENTS MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 117
TABLE 93 ROW: IN VITRO FERTILIZATION EQUIPMENT MARKET SIZE, BY TYPE,  
2014–2021 (USD MILLION) 118
TABLE 94 ROW: IN VITRO FERTILIZATION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 118
TABLE 95 RECENT DEVELOPMENTS, 2013–2016 123
TABLE 96 RECENT DEVELOPMENTS, 2013–2016 124
TABLE 97 RECENT DEVELOPMENTS, 2013–2016 125
TABLE 98 RECENT DEVELOPMENTS, 2013–2016 126
TABLE 99 RECENT DEVELOPMENTS, 2013–2016 127
TABLE 100 RECENT DEVELOPMENTS, 2013–2016 128
 
List Of Figures
FIGURE 1 GLOBAL IN VITRO FERTILIZATION MARKET: RESEARCH METHODOLOGY STEPS 18
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, 
AND REGION 20
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 23
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 23
FIGURE 5 RESEARCH DESIGN 24
FIGURE 6 DATA TRIANGULATION METHODOLOGY 25
FIGURE 7 REAGENTS SEGMENT TO DOMINATE THE GLOBAL IN VITRO FERTILIZATION MARKET IN 2016 28
FIGURE 8 ICSI TECHNOLOGY SEGMENT WILL CONTINUE TO DOMINATE THE IVF MARKET 
IN 2021 29
FIGURE 9 FERTILITY AND SURGICAL CENTERS SEGMENT TO DOMINATE THE GLOBAL IN VITRO FERTILIZATION MARKET IN 2016 30
FIGURE 10 ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 31
FIGURE 11 GLOBAL IN VITRO FERTILIZATION MARKET PROJECTED TO GROW AT A DOUBLE-DIGIT CAGR FROM 2016 TO 2021 32
FIGURE 12 ICSI TECHNOLOGY TO DOMINATE THE IVF MARKET IN 2016 33
FIGURE 13 ASIA-PACIFIC REGION TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 34
FIGURE 14 FERTILITY AND SURGICAL CENTERS TO COMMAND THE LARGEST SHARE IN 2016 34
FIGURE 15 IN VITRO FERTILIZATION MARKET SEGMENTATION 36
FIGURE 16 IN VITRO FERTILIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 37
FIGURE 17 REDUCTION IN THE MEAN AGE OF CHILDBEARING, BY REGION 38
FIGURE 18 REDUCTION IN NUMBER OF BIRTHS PER WOMEN (2003-2050) 39
FIGURE 19 REAGENTS TO ACCOUNT FOR THE LARGEST SHARE OF THE IN VITRO FERTILIZATION MARKET IN 2016 44
FIGURE 20 EMBRYO CULTURE MEDIA TO ACCOUNT FOR THE LARGEST SHARE OF IN VITRO FERTILIZATION REAGENTS MARKET IN 2016 45
FIGURE 21 IMAGING SYSTEMS TO ACCOUNT FOR THE LARGEST SHARE OF THE IN VITRO FERTILIZATION EQUIPMENT MARKET IN 2016 50
FIGURE 22 INTRA-CYTOPLASMIC SPERM INJECTION TECHNOLOGY TO ACCOUNT FOR THE LARGEST SHARE OF IN VITRO FERTILIZATION MARKET IN 2016 63
FIGURE 23 FERTILITY AND SURGICAL CENTERS TO ACCOUNT FOR THE LARGEST SHARE OF THE IN VITRO FERTILIZATION MARKET IN 2016 69
FIGURE 24 ASIA-PACIFIC TO COMMAND THE LARGEST SHARE OF THE IN VITRO FERTILIZATION MARKET IN 2016 76
FIGURE 25 NORTH AMERICAN IN VITRO FERTILIZATION MARKET SNAPSHOT 77
FIGURE 26 EUROPE IN VITRO FERTILIZATION MARKET SNAPSHOT 88
FIGURE 27 ASIA-PACIFIC IN VITRO FERTILIZATION MARKET SNAPSHOT, 2016 100
FIGURE 28 ROW IN VITRO FERTILIZATION MARKET SNAPSHOT, 2016 116
FIGURE 29 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 119
FIGURE 30 KEY DEVELOPMENTS ADOPTED BY THE LEADING PLAYERS IN THE MARKET FROM 2013 TO 2016 121
FIGURE 31 NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 121
FIGURE 32 NEW PRODUCT LAUNCHES, BY COMPANY (2013–2016) 122
FIGURE 33 ACQUISITIONS, BY COMPANY (2013–2016) 123
FIGURE 34 AGREEMENTS, COLLABORATIONS, ALLIANCES, AND PARTNERSHIPS, BY COMPANY (2013–2016) 125
FIGURE 35 PRODUCT APPROVALS, BY COMPANY (2013–2016) 126
FIGURE 36 EXPANSIONS, BY COMPANY (2013–2016) 127
FIGURE 37 OTHER STRATEGIES, BY COMPANY (2013–2016) 128
FIGURE 38 GEOGRAPHICAL REVENUE MIX OF THE LEADING PLAYERS IN THE MARKET 129
FIGURE 39 COMPANY SNAPSHOT: COOPERSURGICAL. INC. 130
FIGURE 40 COMPANY SNAPSHOT: VITROLIFE AB 135
FIGURE 41 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. 144
 
 

关于我们|联系我们|常见问题|服务项目|购买流程
2005-2013 All rights reserved.京ICP备05069564号-4 京公网安备110108 02010359号
全国服务热线:400-009-0050北京:010-82863481上海:021-64871266

在线客服系统